menu search

Merck's keytruda gets u.s. fda's nod for expanded use in lung cancer

The U.S. Food and Drug Administration on Monday approved the expanded use of Merck & Co's blockbuster immuno...

October 16, 2023, 6:58 pm

Immix biopharma completes 3rd nxc-201 engineering batch at its u.s. car-t manufacturing site

Successful completion supports expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the U.S. NXC-201 is manufactured at o...

October 16, 2023, 1:05 pm

Gsk cancer immunotherapy receives backing from key ema committee

GSK PLC (LSE:GSK, NYSE:GSK) said its cancer immunotherapy drug, Jemperli (dostarlimab), has been recom...

October 16, 2023, 4:02 am

Biontech to present multiple program updates across modalities at esmo congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...

October 16, 2023, 3:30 am

: sanofi reaps rewards of immunology investment with eczema results

Pharmaceutical giant set to take on Amgen with atopic dermatitis treatment. Read Full Story The post : Sanofi reaps rewards of ...

October 13, 2023, 2:00 pm

Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunot...

October 13, 2023, 9:05 am

Pharvaris to present at the apaaaci 2023 international conference

ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor a...

October 13, 2023, 6:50 am

Astria therapeutics strikes exclusive license agreement for dermatitis treatment portfolio

Astria Therapeutics has inked a worldwide exclusive license agreement with Ichnos Sciences for an OX40 portfolio targeting the potential treatment of ...

October 12, 2023, 9:33 am

Why is phio pharma (phio) stock down 35% today?

Phio Pharma (NASDAQ: PHIO ) stock is pulling back on Thursday after the immuno-oncology therapeutics c...

October 12, 2023, 8:39 am

Presentations at idweek 2023 highlight potentially differentiated immunogenicity of gritstone bio’s next generation covid-19 vaccine

— High neutralizing antibody (nAb) responses sustained through at least 12 months, highlighting potential for durable clinical protection — — T ...

October 11, 2023, 11:10 am

Anaptys to present phase 1 data on anb032, its btla agonist antibody, at the 32nd eadv congress

SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...

October 11, 2023, 9:15 am

Cybrexa therapeutics to debut preclinical data demonstrating cbx-15 is safe and highly efficacious in 13762 triple negative breast cancer model at 35th aacr-nci-eortc symposium

Preclinical Data Demonstrate CBX-15’s Anti-Tumor Efficacy in Animal Models and Ability to Enhance immuno...

October 10, 2023, 12:05 pm

Merck immunotherapy shows further promise in lung cancer

Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a phase III clinical trial,  showi...

October 10, 2023, 9:11 am

Harpoon therapeutics to present interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023

SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage ...

October 9, 2023, 4:17 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel ...

October 9, 2023, 4:10 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel ...

October 9, 2023, 12:10 pm

Gsk reportedly set to shake up r&d opertion

GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday ...

October 9, 2023, 2:14 am

4 stocks that exhibit solid earnings acceleration

Invest in stocks like Catalyst Pharmaceuticals (CPRX), immunoGen (IMGN), Inari Medical (NARI) and Kyndr...

October 6, 2023, 9:01 am

Umoja biopharma to present at the 2023 cell & gene meeting on the mesa

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., a transformative immuno-oncology com...

October 5, 2023, 6:30 pm

Gri bio announces publication of comprehensive invariant nkt (inkt) cell review in frontiers in immunology demonstrating a key role of type 1 inkt cells in modulating various fibrotic conditions

In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in th...

October 5, 2023, 12:45 pm


Search within

Pages Search Results: